Oncologic Outcomes of Cytoreductive Radical Prostatectomy in Patients With Synchronous Metastatic Castration‐Sensitive Prostate Cancer: A Retrospective Analysis
Retrospective analysis shows improved oncologic outcomes in selected patients with metastatic castration-sensitive prostate cancer, suggesting treatment efficacy.
Key Points
This analysis aims to evaluate the oncologic outcomes of cytoreductive radical prostatectomy in patients with metastatic castration-sensitive prostate cancer.
Retrospective analysis of patients undergoing cytoreductive radical prostatectomy
Assessment of pathological information post-surgery
Evaluation of survival outcomes related to treatment
Cytoreductive radical prostatectomy is feasible and safe for selected patients
Critical pathological information, especially pTE, correlates with better survival outcomes
Incorporating cRP could enhance multimodal treatment strategies for prostate cancer